Related Experiment Video
Updated: Apr 29, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Large-vessel involvement in giant cell arteritis and polymyalgia rheumatica
Francesco Muratore1, Giulia Pazzola, Nicolò Pipitone
1Rheumatology Unit, Department of Internal Medicine, Azienda Ospedaliera ASMN, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy. muratore.francesco@asmn.re.it.
Insights
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are related conditions. Large-vessel involvement (LVI) is increasingly found in GCA, potentially causing serious complications, while rare in PMR.
Area of Science:
- Rheumatology
- Vascular Medicine
- Internal Medicine
Background:
- Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are inflammatory conditions affecting older adults.
- Large-vessel involvement (LVI) is increasingly recognized in GCA, with potential for severe vascular complications.
- Vascular complications are rare in PMR, but overlap between GCA and PMR is common.
Purpose of the Study:
- To review current understanding of large-vessel involvement (LVI) in GCA and PMR.
- To address controversies in the diagnosis, monitoring, and management of LVI in these conditions.
- To highlight the clinical significance of LVI in GCA versus PMR.
Main Methods:
- Literature review of recent studies on LVI in GCA and PMR.
- Analysis of diagnostic modalities for LVI.
- Discussion of management strategies for vascular complications.
Main Results:
- LVI is increasingly detected in GCA using advanced imaging, leading to complications like aortic aneurysms and dissections.
- Limb artery stenosis is a recognized complication of LVI in GCA.
- Vascular complications directly attributed to PMR are exceedingly rare.
Conclusions:
- LVI is a significant concern in GCA, necessitating careful diagnosis and management.
- The role and management of LVI in PMR require further clarification.
- Distinguishing LVI in GCA from PMR is crucial for appropriate patient care.
Abstract:
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are closely related disorders that affect people of middle age and older, and frequently occur together. With the widespread use of newer vascular imaging modalities, large-vessel involvement (LVI) has increasingly been recognised in patients with GCA and less often in those with PMR. LVI in GCA can result in complications such as aortic aneurysm and dissection, aortic arch syndrome, and limb arteries stenosis, while vascular complications in PMR are exceedingly rare. It is still controversial which patients should be investigated for LVI, and how LVI should be diagnosed, monitored and managed. In this review, we will try to address six important issues regarding LVI in GCA and PMR.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Hypersensitivity Reactions: Immune-Complex Reactions
Myasthenia Gravis ll: Pathophysiology
Chronic Inflammation: Introduction

